CopyMark Law Group
4.9/5
Drawing for F-STAR

USPTO serial 88391681

F-STAR

Reviewed by CopyMark Law Group

Reg. 6040409Status 700Registered
Filing date
Status date
Registration date
Apr 28, 2020
Examiner
WHITTAKER BROWN, TRACY
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with F-STAR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shoko Naruo

Shoko Naruo THOMPSON COBURN LLPONE US BANK PLAZAST. LOUIS, MO 63101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemical and biological preparations for scientific use, in particular libraries of immunoglobulins, antibodies, or fragments thereofACTIVE—
005Pharmaceutical preparations, in particular preparations based on immunoglobulins, antibodies, or parts thereof for treatment of cancer, infectious diseases, inflammation and diseases and conditions associated with inflammation, inflammatory diseases, and neurological diseases; Pharmaceutical and biopharmaceutical preparations, including drugs, for medical use, in particular immunoglobulins, antibodies, or fragments thereof, namely, preparations for treatment of cancer, infectious diseases, inflammation and diseases and conditions associated with inflammation, inflammatory diseases, and neurological diseasesACTIVE—
042Scientific and technological services, namely, scientific research and design in the field of pharmaceutical and biopharmaceutical products; Drug discovery services; Scientific research for medical purposes in the field of medicines; Research and development of medicines; Product development for others, namely, development of pharmaceutical preparations and medicines; Scientific research, namely, industrial analysis and research services, in particular for selecting and preparing immunoglobulins, antibodies, or parts thereof for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Oct 30, 2024ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
May 19, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 28, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 11, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 11, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 22, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 7, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 20, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2019ALIEASSIGNED TO LIE—
Dec 5, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 27, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 27, 2019DOCKASSIGNED TO EXAMINER—
May 4, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 22, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance